Discover CSL Ltd's groundbreaking patent for proteins targeting the hG-CSFR receptor, paving the way for innovative antibody therapies against G-CSF signaling.

Savara says it will in the first of half next year seek an FDA license to treat autoimmune pulmonary alveolar proteinosis ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

A group of advanced practice providers discuss treatment options for a woman with newly diagnosed, transplant-ineligible ...

However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor ...

Tocilizumab -- an interleukin (IL)-6 receptor inhibitor -- was approved by the FDA in 2017 for the treatment of severe or ...

Objective To identify differentially expressed genes in temporal artery biopsies (TABs) from patients with giant cell arteritis (GCA) with different histological patterns of inflammation: transmural ...

The world’s first stem cell register was set up by Shirley Nolan in her determination to save her son’s life by finding him a ...

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced ...

India: A recent case report published in Cureus underscores the serious risks associated with methotrexate toxicity, ...

The liver function in post-cardiac arrest brain injury is not known and was investigated in a pig model of global cerebral ...

Omitting the 5-FU bolus from multidrug regimens could improve tolerability without compromising efficacy in advanced gastrointestinal cancers.